Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)

[1]  C. Magi-Galluzzi,et al.  Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin) , 2014, Molecular Cancer.

[2]  S. Conti,et al.  Autophagy in Prostate Cancer and Androgen Suppression Therapy , 2013, International journal of molecular sciences.

[3]  D. Rubinsztein,et al.  Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.

[4]  C. Thompson,et al.  Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.

[5]  Kamini Singh,et al.  Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress , 2012, Autophagy.

[6]  Yuehua Wu,et al.  AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia. , 2011, Cellular signalling.

[7]  Shengbing Huang,et al.  The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.

[8]  N. Mizushima,et al.  p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding , 2011, The Journal of cell biology.

[9]  Guido Kroemer,et al.  Autophagy and the integrated stress response. , 2010, Molecular cell.

[10]  A. Ashkenazi,et al.  New insights into apoptosis signaling by Apo2L/TRAIL , 2010, Oncogene.

[11]  Giuseppe Floris,et al.  Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST) , 2010, Proceedings of the National Academy of Sciences.

[12]  K. Lam,et al.  Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors. , 2010, Genes & cancer.

[13]  G. Bjørkøy,et al.  Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies* , 2009, The Journal of Biological Chemistry.

[14]  M. Butterworth,et al.  Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. , 2009, Molecular cell.

[15]  Ivan Dikic,et al.  A role for ubiquitin in selective autophagy. , 2009, Molecular cell.

[16]  D. Lawrence,et al.  Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling , 2009, Cell.

[17]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[18]  P. Jaakkola,et al.  p62 degradation by autophagy: Another way for cancer cells to survive under hypoxia , 2009, Autophagy.

[19]  H. Zentgraf,et al.  TNF‐α‐ and TRAIL‐resistant glioma cells undergo autophagy‐dependent cell death induced by activated microglia , 2009, Glia.

[20]  A. López-Rivas,et al.  TAK1 activates AMPK‐dependent cytoprotective autophagy in TRAIL‐treated epithelial cells , 2009, The EMBO journal.

[21]  Nektarios Tavernarakis,et al.  Autophagy and cell death in model organisms , 2009, Cell Death and Differentiation.

[22]  D. Klionsky,et al.  Atg8 controls phagophore expansion during autophagosome formation. , 2008, Molecular biology of the cell.

[23]  D. Stolz,et al.  Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells* , 2008, Journal of Biological Chemistry.

[24]  G. Cavet,et al.  Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL , 2007, Nature Medicine.

[25]  Y. Ohsumi,et al.  Atg8, a Ubiquitin-like Protein Required for Autophagosome Formation, Mediates Membrane Tethering and Hemifusion , 2007, Cell.

[26]  S. Ray,et al.  S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11–induced apoptosis of prostate cancer cells , 2007, Molecular Cancer Therapeutics.

[27]  Terje Johansen,et al.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.

[28]  Guido Kroemer,et al.  Lysosomes and autophagy in cell death control , 2005, Nature Reviews Cancer.

[29]  S. Ray,et al.  Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. , 2003, Cancer research.

[30]  A. Ashkenazi,et al.  Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. , 2003, Cytokine & growth factor reviews.

[31]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.